Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein.

Fletcher S, Drewry JA, Shahani VM, Page BD, Gunning PT.

Biochem Cell Biol. 2009 Dec;87(6):825-33. doi: 10.1139/o09-044. Review.

PMID:
19935868
2.

CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets.

Yu J, Mao HC, Wei M, Hughes T, Zhang J, Park IK, Liu S, McClory S, Marcucci G, Trotta R, Caligiuri MA.

Blood. 2010 Jan 14;115(2):274-81. doi: 10.1182/blood-2009-04-215491. Epub 2009 Nov 6.

3.

CD94 defines phenotypically and functionally distinct mouse NK cell subsets.

Yu J, Wei M, Mao H, Zhang J, Hughes T, Mitsui T, Park IK, Hwang C, Liu S, Marcucci G, Trotta R, Benson DM Jr, Caligiuri MA.

J Immunol. 2009 Oct 15;183(8):4968-74. doi: 10.4049/jimmunol.0900907.

4.

Antibody-based therapy of leukaemia.

Morris JC, Waldmann TA.

Expert Rev Mol Med. 2009 Sep 30;11:e29. doi: 10.1017/S1462399409001215. Review.

PMID:
19788782
5.

A novel mouse model for the aggressive variant of NK cell and T cell large granular lymphocyte leukemia.

Yokohama A, Mishra A, Mitsui T, Becknell B, Johns J, Curphey D, Blaser BW, Vandeusen JB, Mao H, Yu J, Caligiuri MA.

Leuk Res. 2010 Feb;34(2):203-9. doi: 10.1016/j.leukres.2009.06.031. Epub 2009 Aug 5.

6.

Interleukin-15 enhances proteasomal degradation of bid in normal lymphocytes: implications for large granular lymphocyte leukemias.

Hodge DL, Yang J, Buschman MD, Schaughency PM, Dang H, Bere W, Yang Y, Savan R, Subleski JJ, Yin XM, Loughran TP Jr, Young HA.

Cancer Res. 2009 May 1;69(9):3986-94. doi: 10.1158/0008-5472.CAN-08-3735. Epub 2009 Apr 14.

7.

TSC-22 contributes to hematopoietic precursor cell proliferation and repopulation and is epigenetically silenced in large granular lymphocyte leukemia.

Yu J, Ershler M, Yu L, Wei M, Hackanson B, Yokohama A, Mitsui T, Liu C, Mao H, Liu S, Liu Z, Trotta R, Liu CG, Liu X, Huang K, Visser J, Marcucci G, Plass C, Belyavsky AV, Caligiuri MA.

Blood. 2009 May 28;113(22):5558-67. doi: 10.1182/blood-2009-02-205732. Epub 2009 Mar 27.

8.

Network model of survival signaling in large granular lymphocyte leukemia.

Zhang R, Shah MV, Yang J, Nyland SB, Liu X, Yun JK, Albert R, Loughran TP Jr.

Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16308-13. doi: 10.1073/pnas.0806447105. Epub 2008 Oct 13.

9.

Umbilical cord blood T cells express multiple natural cytotoxicity receptors after IL-15 stimulation, but only NKp30 is functional.

Tang Q, Grzywacz B, Wang H, Kataria N, Cao Q, Wagner JE, Blazar BR, Miller JS, Verneris MR.

J Immunol. 2008 Oct 1;181(7):4507-15.

10.

Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes.

Shah MV, Zhang R, Irby R, Kothapalli R, Liu X, Arrington T, Frank B, Lee NH, Loughran TP Jr.

Blood. 2008 Aug 1;112(3):770-81. doi: 10.1182/blood-2007-11-121871. Epub 2008 May 13.

11.

Oncogenes and tumour suppressors take on centrosomes.

Fukasawa K.

Nat Rev Cancer. 2007 Dec;7(12):911-24. Review.

PMID:
18004399
12.

Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1.

Huntington ND, Puthalakath H, Gunn P, Naik E, Michalak EM, Smyth MJ, Tabarias H, Degli-Esposti MA, Dewson G, Willis SN, Motoyama N, Huang DC, Nutt SL, Tarlinton DM, Strasser A.

Nat Immunol. 2007 Aug;8(8):856-63. Epub 2007 Jul 8.

13.

Invariant NKT and NKT-like lymphocytes: two different T cell subsets that are differentially affected by ageing.

Peralbo E, Alonso C, Solana R.

Exp Gerontol. 2007 Aug;42(8):703-8. Epub 2007 May 21. Review.

PMID:
17604928
14.

TGF-beta 1 regulates antigen-specific CD4+ T cell responses in the periphery.

Robinson RT, Gorham JD.

J Immunol. 2007 Jul 1;179(1):71-9.

15.

Natural killer cells: from CD3(-)NKp46(+) to post-genomics meta-analyses.

Walzer T, Jaeger S, Chaix J, Vivier E.

Curr Opin Immunol. 2007 Jun;19(3):365-72. Epub 2007 Apr 17. Review.

PMID:
17442558
16.

Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46.

Walzer T, Bléry M, Chaix J, Fuseri N, Chasson L, Robbins SH, Jaeger S, André P, Gauthier L, Daniel L, Chemin K, Morel Y, Dalod M, Imbert J, Pierres M, Moretta A, Romagné F, Vivier E.

Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3384-9. Epub 2007 Feb 20.

17.

Therapy of peripheral T/NK neoplasms.

Greer JP.

Hematology Am Soc Hematol Educ Program. 2006:331-7. Review.

PMID:
17124080
18.
19.

IL-15/IL-15 receptor biology: a guided tour through an expanding universe.

Budagian V, Bulanova E, Paus R, Bulfone-Paus S.

Cytokine Growth Factor Rev. 2006 Aug;17(4):259-80. Epub 2006 Jun 30. Review.

PMID:
16815076
20.

Reprogramming of CTLs into natural killer-like cells in celiac disease.

Meresse B, Curran SA, Ciszewski C, Orbelyan G, Setty M, Bhagat G, Lee L, Tretiakova M, Semrad C, Kistner E, Winchester RJ, Braud V, Lanier LL, Geraghty DE, Green PH, Guandalini S, Jabri B.

J Exp Med. 2006 May 15;203(5):1343-55. Epub 2006 May 8.

Supplemental Content

Support Center